@article{06b8035c66bd42f3a86ccf7dab997d64,
title = "Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study",
keywords = "combination therapy, dipeptidyl peptidase-4, DPP-IV inhibitor, glycaemic control, linagliptin, metformin, metformin add-on, type 2 diabetes, DIPEPTIDYL PEPTIDASE-4 INHIBITOR, GLUCAGON-LIKE PEPTIDE-1, GLYCEMIC CONTROL, MELLITUS, VILDAGLIPTIN, MONOTHERAPY, PHARMACOKINETICS, PHARMACODYNAMICS, TOLERABILITY, MANAGEMENT",
author = "Marja-Riitta Taskinen and J. Rosenstock and I. Tamminen and R. Kubiak and S. Patel and Dugi, {K. A.} and Woerle, {H. -J.}",
year = "2011",
doi = "10.1111/j.1463-1326.2010.01326.x",
language = "English",
volume = "13",
pages = "65--74",
journal = "Diabetes, obesity and metabolism",
issn = "1462-8902",
publisher = "Wiley",
number = "1",
}